MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 195 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,369,270 | -30.8% | 136,927 | -14.0% | 0.00% | 0.0% |
| Q2 2023 | $1,979,315 | +108000.2% | 159,237 | +21.8% | 0.00% | 0.0% |
| Q1 2023 | $1,831 | +8.2% | 130,694 | +10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,692 | -99.9% | 118,231 | +6.1% | 0.00% | -50.0% |
| Q3 2022 | $2,846,000 | -5.4% | 111,482 | +5.3% | 0.00% | 0.0% |
| Q2 2022 | $3,009,000 | -9.0% | 105,901 | +13.0% | 0.00% | 0.0% |
| Q1 2022 | $3,306,000 | -18.2% | 93,736 | -2.8% | 0.00% | -20.0% |
| Q4 2021 | $4,040,000 | -3.0% | 96,428 | +13.6% | 0.01% | -16.7% |
| Q3 2021 | $4,164,000 | +47.7% | 84,851 | +25.6% | 0.01% | +50.0% |
| Q2 2021 | $2,819,000 | +23.9% | 67,553 | +5.8% | 0.00% | +33.3% |
| Q1 2021 | $2,276,000 | – | 63,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |